Oral Sedation in Vitreoretinal Surgery (NCT04346095) | Clinical Trial Compass
UnknownPhase 4
Oral Sedation in Vitreoretinal Surgery
80 participantsStarted 2020-06
Plain-language summary
The purpose of this study is to compare the efficacy of oral sedation to intravenous sedation with anesthesiology support and monitoring.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Undergoing vitreoretinal surgery for a variety of indications including, but not limited to, epiretinal membrane (ERM), macular hole, vitreous opacities, vitreous hemorrhage, aphakia, dislocated or displaced intraocular or crystalline lens, silicone removal, endolaser, and retinal detachment.
* American Society of Anesthesiologists rating of I-III
Exclusion Criteria:
* Undergoing vitreoretinal surgery requiring general anesthesia
* Allergy or hypersensitivity to benzodiazepines
* Pregnant or nursing females
* Previous delirium after anesthesia
* Current use of drug or alcohol on the day of surgery
* Currently on medications inhibiting cytochrome P450
* Failed anesthesia clearance
* Reported anxiety or a history of anxiolytic use
* Vitreoretinal surgery performed within the last 3 months of the current procedure
* Impaired renal or liver function
What they're measuring
1
Patient satisfaction: scale
Timeframe: A patient satisfaction survey will be completed at the one-day post operative appointment.